Abstract

There is depressed prevalence of the optimum iron-folate supplementation in Kenya and in other sub-Saharan Africa countries. The study was motivated by the paucity of area-specific data on predictors of optimum iron-folate supplementation. The aim of the study was to assess the maternal, knowledge and institutional factors that predict 90+ days (optimum) iron-folate supplementation among pregnant women in a rural set-up in Eastern Kenya. A descriptive cross-sectional study to collect quantitative data from 352 mothers of under-five years old children attending 7 health facilities in Kalama Division of Machakos constituency within Machakos County in lower Eastern Kenya. Using a standard questionnaire, mothers recalled the number of days they had ingested iron-folate supplements in their latest pregnancies. The overall prevalence of optimum supplementation (90+ days) during latest pregnancies was 18.3% and on average the study mothers were supplemented for ~38 days during the antenatal period. Mothers who visited antenatal care (ANC) for ≥4days (odd ratio [OR]: 2.756, 95% confidence interval [CI]: 1.396-5.445) were more likely to take iron-folate supplements for 90+ days and be supplemented for more days (45.8) than <4 days visitors (26.2 days), p=0.017. Earlier ANC visit was associated with the mean days of supplementation (p=0.006), but not with optimum supplementation (OR: 0.412, 95% CI: 0.236-0.719). Knowledge on supplementation for a minimum of 90 days predicted optimum supplementation (OR: 5.872, 95% CI: 2.945 -11.709). Knowledge on when to start supplementation and importance of supplementation only predicted higher days of supplementation (p<0.05), but not the optimum supplementation. Pregnant women who used tablet form were more likely to be supplemented optimally (OR: 1.007, 95% CI: 1.004-1.116).  Those who were supplemented with a combined form of supplement were more likely to have more days of supplementation (p=0.004), but not optimum (OR: 1.125, 95% CI: 0.419-3.021) compared to those who used single iron and folate supplement. To increase the proportion of pregnant mothers taking iron-folate supplements for 90+ days in low resource rural set-ups, there should be intensified counselling/education on ANC attendance ≥ 4 times and on minimum number of days for optimum iron-folate supplementation. Use of tablets as opposed to syrup increases the likelihood for antenatal ingestion of iron-folate supplements for 90+ days in rural low-resource set-up.   Key words: Predictors, optimum supplementation, iron-folate supplements, pregnant women

Highlights

  • Iron and folate supplementation during pregnancy is important for sound maternal health and favourable perinatal outcomes

  • World Health Organisation (WHO) currently recommends 30 to 60 mg of elemental iron and 400 μg (0.4 mg) of folic acid taken by all pregnant adolescents and adult women, that started as early as possible and taken throughout pregnancy, one supplement a day (WHO, 2012)

  • This study reports the days of antenatal iron-folate supplementation, proportion optimally supplementation and factors that predict supplementation

Read more

Summary

Introduction

Iron and folate supplementation during pregnancy is important for sound maternal health and favourable perinatal outcomes. The need for folic acid increases during times of rapid tissue growth which during pregnancy includes an increase in red blood cell mass, enlargement of the uterus, and the growth of the placenta and foetus (Bailey, 2000). World Health Organisation (WHO) currently recommends 30 to 60 mg of elemental iron and 400 μg (0.4 mg) of folic acid taken by all pregnant adolescents and adult women, that started as early as possible and taken throughout pregnancy, one supplement a day (WHO, 2012). Kenya is one of the countries that register very low proportions of pregnant women supplemented for at least 90 days during pregnancy. In Ethiopia (a neighbouring country to Kenya) this figure stands at 0.4% (Gebremedhin et al, 2014) These are very low coverage figures given that almost half of the women of reproductive age in Kenya for instance, are anaemic (GOK and UNICEF, 1999)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.